Get started
Author

Hsiao‐Huai Kuo

Observed names: H H Kuo, Hsiao-Huai Kuo
ORCID: 0000-0001-9758-1232
Observed ORCID: 0000-0001-9758-1232
OpenAlex ID: A5081369394
Cardiovascular outcomes associated with SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cancer: a systematic review and meta-analysis
2024 · Hsiao-Huai Kuo, Kuang-Te Wang, et al. · Diabetology & Metabolic Syndrome · 22
The impact of COVID-19 on routine vaccinations in Taiwan and an unexpected surge of pneumococcal vaccination
2022 · Nan-Chang Chiu, Kai-Hsun Lo, et al. · Human Vaccines & Immunotherapeutics · 20
PDF
Effects of canagliflozin on cardiac remodeling and hemodynamic parameters in patients with type 2 diabetes mellitus
2023 · Hsiao-Huai Kuo, Yau-Huei Lai, et al. · Scientific Reports · 9
PDF
Effects of lorcaserin on cardiometabolic risk factors in overweight and obese patients: A systematic review and meta‐analysis
2019 · Hsiao‐Huai Kuo, Kuang‐Te Wang, et al. · Journal of Clinical Pharmacy and Therapeutics · 6
PDF
Preeclampsia in multiple pregnancy.
1995 · H H Kuo, J M Yang, et al. · PubMed · 5
Effects of SGLT2 inhibitors on the cardiovascular outcomes in patients with cancer: a systematic review and meta-analysis
2024 · L Liu, H H Chen, et al. · European Heart Journal · 3
Canagliflozin improves hemodynamic parameters by impedance cardiography and left ventricular diastolic function in patients with type 2 diabetes mellitus
2023 · L Liu, H H Kuo, et al. · European Heart Journal
PDF
P4414Effects of lorcaserin on the cardiometabolic risk factors in overweight or obese patients: a systematic review and meta-analysis
2019 · H H Kuo, M E Liu, et al. · European Heart Journal
Metformin for patients under iodine-based contrast medium
2016 · Hsiao-Huai Kuo, Chia-Wen Hsieh, et al. · Diabetes Research and Clinical Practice
Works count: 9
Citation count: 65
H-index: 5
I10-index: 2
Year
Topic
Type